The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCO 2019 | Pre-treatment PET scans
Here, Paolo Strati, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, discusses the benefits of pre-treatment PET scans to identify areas of risk for transformation to large B-cell lymphomas and the significance of baseline maximum standardized uptake values (SUVmax). This interview was recorded at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.
